IRIS Accounts Production v24.3.0.553 12257600 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122576002023-03-31122576002024-03-31122576002023-04-012024-03-31122576002022-03-31122576002022-04-012023-03-31122576002023-03-3112257600ns15:EnglandWales2023-04-012024-03-3112257600ns14:PoundSterling2023-04-012024-03-3112257600ns10:Director12023-04-012024-03-3112257600ns10:CompanyLimitedByGuarantee2023-04-012024-03-3112257600ns10:SmallEntities2023-04-012024-03-3112257600ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112257600ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112257600ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112257600ns10:FullAccounts2023-04-012024-03-3112257600ns10:Director22023-04-012024-03-3112257600ns10:Director32023-04-012024-03-3112257600ns10:Director52023-04-012024-03-3112257600ns10:Director62023-04-012024-03-3112257600ns10:Director72023-04-012024-03-3112257600ns10:Director82023-04-012024-03-3112257600ns10:RegisteredOffice2023-04-012024-03-3112257600ns5:CurrentFinancialInstruments2024-03-3112257600ns5:CurrentFinancialInstruments2023-03-3112257600ns5:RetainedEarningsAccumulatedLosses2024-03-3112257600ns5:RetainedEarningsAccumulatedLosses2023-03-3112257600ns5:ComputerEquipment2023-04-012024-03-3112257600ns5:ComputerEquipment2023-03-3112257600ns5:ComputerEquipment2024-03-3112257600ns5:ComputerEquipment2023-03-3112257600ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3112257600ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3112257600ns5:WithinOneYear2024-03-3112257600ns5:WithinOneYear2023-03-3112257600ns5:BetweenOneFiveYears2024-03-3112257600ns5:BetweenOneFiveYears2023-03-3112257600ns5:AllPeriods2024-03-3112257600ns5:AllPeriods2023-03-31
REGISTERED NUMBER: 12257600 (England and Wales)






























UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

UK CLINICAL PHARMACY ASSOCIATION
LIMITED

UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


UK CLINICAL PHARMACY ASSOCIATION
LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr R M Bednall
Mr I S M S Elkonaissi
Mr M H Rahman
Mrs F Khan
Mr B Tomaszewicz
Mr J G Warburton
Mrs K P Webb





REGISTERED OFFICE: Granville Hall
Granville Road
Leicester
LE1 7RU





REGISTERED NUMBER: 12257600 (England and Wales)

UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,429 2,234

CURRENT ASSETS
Debtors 5 3,197 17,668
Cash at bank 746,235 848,606
749,432 866,274
CREDITORS
Amounts falling due within one year 6 37,773 98,356
NET CURRENT ASSETS 711,659 767,918
TOTAL ASSETS LESS CURRENT
LIABILITIES

714,088

770,152

PROVISIONS FOR LIABILITIES 608 559
NET ASSETS 713,480 769,593

RESERVES
Income and expenditure account 713,480 769,593
713,480 769,593

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2024 and were signed on its behalf by:





Mrs K P Webb - Director


UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

UK Clinical Pharmacy Association Limited is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue comprises of membership fees, course income and sponsorship. The company provides memberships and courses to customers under standard terms and conditions. Revenue is recognised upon completion of the services. Revenue for membership fees is recognised over the term of the membership period.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to surplus or deficit on a straight line basis over the period of the lease.

UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Payments in respect of other post-retirement benefits are charged to profit or loss in the period to which they relate.


Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 5 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2023 3,394
Additions 1,986
At 31 March 2024 5,380
DEPRECIATION
At 1 April 2023 1,160
Charge for year 1,791
At 31 March 2024 2,951
NET BOOK VALUE
At 31 March 2024 2,429
At 31 March 2023 2,234

UK CLINICAL PHARMACY ASSOCIATION
LIMITED (REGISTERED NUMBER: 12257600)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 2,072 13,865
Other debtors 1,125 3,803
3,197 17,668

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 9,009 20,157
Taxation and social security 394 3,070
Other creditors 28,370 75,129
37,773 98,356

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year - 4,800
Between one and five years - 400
- 5,200

8. PENSION COMMITMENTS

The company operates a pension scheme. The assets of the scheme are held separately from those of the company within independently administered funds. The charge for the year was £4,140 (2023: £2,742).